To supercharge science, first experiment with how it is funded
Too much of researchers’ time is spent filling in forms
The transformation unleashed by increased funding for science during the 20th century is nothing short of remarkable. In the early 1900s research was a cottage industry mostly funded by private firms and philanthropy. Thomas Edison electrified the world from his industrial lab at Menlo Park, and the Carnegie Corporation was the principal backer of Edwin Hubble. Advances in science during the second world war—from the development of radar to the atom bomb—led governments and companies to scale things up. By the mid-1960s America’s federal government was spending 0.6% of gdp on research funding and the share of overall investment in research and development rose to nearly 3%. Inventions including the internet, GPS and space telescopes followed.
This article appeared in the Leaders section of the print edition under the headline “Time to experiment ”
Leaders November 18th 2023
- Donald Trump poses the biggest danger to the world in 2024
- The rights and wrongs of Israel and Hamas at al-Shifa hospital
- Will Japan rediscover its dynamism?
- The world is ignoring war, genocide and famine in Sudan
- To supercharge science, first experiment with how it is funded
- If Labour is to succeed in power, it must fix the Treasury
More from Leaders
Sir Keir Starmer should aim higher in his reset with the EU
And he needs to be clearer about what Britain wants
To make electricity cheaper and greener, connect the world’s grids
Less than 3% of the world’s power is internationally traded—a huge wasted opportunity
Chinese AI is catching up, posing a dilemma for Donald Trump
The success of cheap Chinese models threatens America’s technological lead
America has an imperial presidency
And in Donald Trump, an imperialist president for the first time in over a century
Tariffs will harm America, not induce a manufacturing rebirth
Donald Trump’s pursuit of tariffs will make the world poorer—and America, too
How to improve clinical trials
Involving more participants can lead to new medical insights